TY - JOUR
T1 - Cooling of the epileptic focus suppresses seizures with minimal influence on neurologic functions
AU - Fujii, Masami
AU - Inoue, Takao
AU - Nomura, Sadahiro
AU - Maruta, Yuichi
AU - He, Yeting
AU - Koizumi, Hiroyasu
AU - Shirao, Satoshi
AU - Owada, Yuji
AU - Kunitsugu, Ichiro
AU - Yamakawa, Toshitaka
AU - Tokiwa, Tatsuji
AU - Ishizuka, Satoshi
AU - Yamakawa, Takeshi
AU - Suzuki, Michiyasu
PY - 2012/3
Y1 - 2012/3
N2 - Purpose: Focal brain cooling is effective for suppression of epileptic seizures, but it is unclear if seizures can be suppressed without a substantial influence on normal neurologic function. To address the issue, a thermoelectrically driven cooling system was developed and applied in free-moving rat models of focal seizure and epilepsy. Methods: Focal seizures limited to the unilateral forelimb were induced by local application of a penicillin G solution or cobalt powder to the unilateral sensorimotor cortex. A proportional integration and differentiation (PID)-controlled, thermoelectrically driven cooling device (weight of 11 g) and bipolar electrodes were chronically implanted on the eloquent area (on the epileptic focus) and the effects of cooling (20, 15, and 10°C) on electrocorticography, seizure frequency, and neurologic changes were investigated. Key Findings: Cooling was associated with a distinct reduction of the epileptic discharges. In both models, cooling of epileptic foci significantly improved both seizure frequency and neurologic functions from 20°C down to 15°C. Cooling to 10°C also suppressed seizures, but with no further improvement in neurologic function. Subsequent investigation of sensorimotor function revealed significant deterioration in foot-fault tests and the receptive field size at 15°C. Significance: Despite the beneficial effects in ictal rats, sensorimotor functions deteriorated at 15°C, thereby suggesting a lower limit for the therapeutic temperature. These results provide important evidence of a therapeutic effect of temperatures from 20 to 15°C using an implantable, hypothermal device for focal epilepsy.
AB - Purpose: Focal brain cooling is effective for suppression of epileptic seizures, but it is unclear if seizures can be suppressed without a substantial influence on normal neurologic function. To address the issue, a thermoelectrically driven cooling system was developed and applied in free-moving rat models of focal seizure and epilepsy. Methods: Focal seizures limited to the unilateral forelimb were induced by local application of a penicillin G solution or cobalt powder to the unilateral sensorimotor cortex. A proportional integration and differentiation (PID)-controlled, thermoelectrically driven cooling device (weight of 11 g) and bipolar electrodes were chronically implanted on the eloquent area (on the epileptic focus) and the effects of cooling (20, 15, and 10°C) on electrocorticography, seizure frequency, and neurologic changes were investigated. Key Findings: Cooling was associated with a distinct reduction of the epileptic discharges. In both models, cooling of epileptic foci significantly improved both seizure frequency and neurologic functions from 20°C down to 15°C. Cooling to 10°C also suppressed seizures, but with no further improvement in neurologic function. Subsequent investigation of sensorimotor function revealed significant deterioration in foot-fault tests and the receptive field size at 15°C. Significance: Despite the beneficial effects in ictal rats, sensorimotor functions deteriorated at 15°C, thereby suggesting a lower limit for the therapeutic temperature. These results provide important evidence of a therapeutic effect of temperatures from 20 to 15°C using an implantable, hypothermal device for focal epilepsy.
KW - Epilepsy
KW - Focal brain cooling
KW - Implantable device
KW - Therapeutic temperatures
UR - http://www.scopus.com/inward/record.url?scp=84862819938&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862819938&partnerID=8YFLogxK
U2 - 10.1111/j.1528-1167.2011.03388.x
DO - 10.1111/j.1528-1167.2011.03388.x
M3 - Article
C2 - 22292464
AN - SCOPUS:84862819938
SN - 0013-9580
VL - 53
SP - 485
EP - 493
JO - Epilepsia
JF - Epilepsia
IS - 3
ER -